← Leaderboards
Marilyn L Kwan
Kaiser Foundation Research Institute
$12,106,221
Attributed
$29,213,404
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2012–25$5M$3.8M$2.5M$1.3M$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,213,404 · 6
By mechanism
R01$26,620,322 · 5
U01$2,593,082 · 1
Top collaborators
- Li Tang13 shared
- Lawrence H Kushi6 shared
- Diana L Miglioretti5 shared
- Rebecca Smith-Bindman5 shared
- Heather A Greenlee4 shared
- Song Yao4 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Lawrence H Kushi$60,993,337
- Bette J Caan$23,657,335
- Reina Haque$5,883,468
- Song Yao$11,329,919
- Kim N Danforth$2,088,303
Others in their field
Top investigators on “Life Style”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- James E. Gern · University Of Wisconsin-Madison$84,160,094
- Mine Cicek · Mayo Clinic Rochester$80,157,953
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,215,522
- William George Nelson · Johns Hopkins University$63,780,611
- Lloyd D Johnston · University Of Michigan At Ann Arbor$52,441,056
Research focus
Life StyleSmokingDiagnosisHigh RiskMalignant NeoplasmsCaliforniaMedicalNewly DiagnosedLifestyle FactorsCancer PatientCancer PrognosisDietLinkCohortFollow-UpGenesMalignant Neoplasm Of Urinary BladderAdverse EffectsIntravesicalCancer RecurrenceCaringClinical CareCancer DiagnosisMuscle
Grant awards (26)
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$2,683,351
R01 · FY2025 · CA
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$874,216
U01 · FY2025 · CA · contact PI
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,256,124
R01 · FY2024 · CA
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$837,461
U01 · FY2024 · CA · contact PI
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,289,789
R01 · FY2023 · CA
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer$881,405
U01 · FY2023 · CA · contact PI
Transcriptomic classification of non-muscle invasive bladder cancer and its clinical and prognostic implication$1,318,389
R01 · FY2022 · CA
Predictors of CVD among breast cancer survivors in an integrated health system$618,653
R01 · FY2020 · CA · contact PI
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging$1,630,353
R01 · FY2019 · CA
Predictors of CVD among breast cancer survivors in an integrated health system$608,974
R01 · FY2019 · CA · contact PI
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging$2,139,085
R01 · FY2018 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$926,417
R01 · FY2018 · CA · contact PI
Predictors of CVD among breast cancer survivors in an integrated health system$772,793
R01 · FY2018 · CA · contact PI
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$99,577
R01 · FY2018 · CA · contact PI
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging$2,177,040
R01 · FY2017 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$982,302
R01 · FY2017 · CA · contact PI
Predictors of CVD among breast cancer survivors in an integrated health system$616,377
R01 · FY2017 · CA · contact PI
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging$2,196,358
R01 · FY2016 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$986,987
R01 · FY2016 · CA · contact PI
Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging$1,834,140
R01 · FY2015 · CA
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$990,772
R01 · FY2015 · CA · contact PI
Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors$625,919
R01 · FY2015 · CA · contact PI
Diet and Lifestyle in a Prospective Study of Bladder Cancer Survivors$1,039,856
R01 · FY2014 · CA · contact PI
Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors$615,578
R01 · FY2014 · CA · contact PI
Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors$500,071
R01 · FY2013 · CA · contact PI
Lifestyle and Molecular Factors of Bone Health in Breast Cancer Survivors$711,417
R01 · FY2012 · CA · contact PI